EP3766496
ANLOTINIB FOR TREATMENT OF NASOPHARYNGEAL CARCINOMA
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
7.3.2019EP published:
25.2.2026EP application number:
19768631.4
EPO information:
European Patent Register
Max expiry date:
6.3.2039Expiry date:
24.6.2026
Title in English:
ANLOTINIB FOR TREATMENT OF NASOPHARYNGEAL CARCINOMALanguage of the patent:
English
Timeline
Today
7.3.2019EP application
25.2.2026EP Publication
24.6.2026Expires
Owner
Name:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Address:
No. 369 Yuzhou South Road, Lianyungang, Jiangsu 222062, CN
Inventor
Name:
WANG, ShanchunAddress:
Lianyungang, Jiangsu 222062, CN
Name:
SHEN, JunAddress:
Lianyungang, Jiangsu 222062, CN
Name:
HAN, XiAddress:
Lianyungang, Jiangsu 222062, CN
Name:
WANG, XunqiangAddress:
Lianyungang, Jiangsu 222062, CN
Name:
TANG, ShaonanAddress:
Lianyungang, Jiangsu 222062, CN
Name:
CAO, ShuqingAddress:
Lianyungang, Jiangsu 222062, CN
Name:
ZHANG, XiquanAddress:
Lianyungang, Jiangsu 222062, CN
Name:
YU, HaoAddress:
Lianyungang, Jiangsu 222062, CN
Name:
PAN, MaoqiongAddress:
Lianyungang, Jiangsu 222062, CN
Priority
Number:
201810206825Date:
14.3.2018Country:
CN
Classification
Categories:
A61K 31/4709, A61P 35/00